Anogenital cancers testing in Mira

Find health labs to test for Anogenital cancers in Mira and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Synlab

Via Lussinpiccolo, 45, 30174 Venezia VE, Italia

10.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Viale Garibaldi, 50C 30173 Mestre (VE)

10.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Enrico Caviglia, 3, Mestre, Italia c/o Poliambulatorio Bissuola 30173 Mestre (VE)

10.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Roma, 73 35012 Borgoricco (PD)

10.2 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Piazzetta San Marco 2/A Piove di Sacco. 35028 Piove di Sacco (PD)

10.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Ronzinella, 162 31021 Mogliano Veneto (TV)

10.4 km

Unverified

See Details

Pap Smear by Synlab

Via Giovanni Boccaccio, 106, 35128 Padova PD, Italia

12.1 km

Unverified

See Details

Pap Smear by Synlab

Via Libero Benedetti, 2, 35133 Padova PD, Italia

12.1 km

Unverified

See Details

Pap Smear by Synlab

Via Antonio Zanchi, 89, 35133 Padova PD, Italia

12.1 km

Unverified

See Details

Pap Smear by Synlab

Via Egidio Forcellini, 130, 35128 Padova PD, Italia

12.1 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.